Filing Details

Accession Number:
0001144204-13-029990
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-16 17:16:53
Reporting Period:
2013-05-14
Filing Date:
2013-05-16
Accepted Time:
2013-05-16 17:16:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286338 Ann Hanham One Embarcadero Center,
Suite 2700
San Francisco CA 94111-3776
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-14 18,649 $14.94 750,146 No 4 S Indirect By Burrill Life Sciences Capital Fund, L.P.
Common Stock Disposition 2013-05-15 18,464 $14.43 731,682 No 4 S Indirect By Burrill Life Sciences Capital Fund, L.P.
Common Stock Disposition 2013-05-14 1,551 $14.94 62,389 No 4 S Indirect By Burrill Indiana Life Sciences Capital Fund, L.P.
Common Stock Disposition 2013-05-15 1,536 $14.43 60,853 No 4 S Indirect By Burrill Indiana Life Sciences Capital Fund, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Burrill Life Sciences Capital Fund, L.P.
No 4 S Indirect By Burrill Life Sciences Capital Fund, L.P.
No 4 S Indirect By Burrill Indiana Life Sciences Capital Fund, L.P.
No 4 S Indirect By Burrill Indiana Life Sciences Capital Fund, L.P.
Footnotes
  1. Represents the sale of 20,200 shares in multiple transactions, ranging in price from $14.50 to $15.33 per share, resulting in a weighted average sale price per share of $14.94. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
  2. Ann Hanham is a managing member of Burrill & Company (Life Science GP), LLC which has the ultimate voting and investment power over shares held of record by Burrill Life Sciences Capital Fund, L.P., and she may be deemed to have voting and investment power over shares held of record by Burrill Life Sciences Capital Fund, L.P. Ms. Hanham disclaims beneficial ownership of the shares directly held by the entities affiliated with Burrill & Company except to the extent of her individual pecuniary interest therein.
  3. Represents the sale of 20,000 shares in multiple transactions, ranging in price from $14.40 to $14.53 per share, resulting in a weighted average sale price per share of $14.43. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
  4. Ann Hanham is a managing member of Burrill & Company (Indiana GP), LLC which has the ultimate voting and investment power over shares held of record by Burrill Indiana Life Sciences Capital Fund, L.P., and she may be deemed to have voting and investment power over shares held of record by Burrill Indiana Life Sciences Capital Fund, L.P. Ms. Hanham disclaims beneficial ownership of the shares directly held by the entities affiliated with Burrill & Company except to the extent of her individual pecuniary interest therein.